首页> 外文期刊>International Journal of Biological Macromolecules: Structure, Function and Interactions >In vitro immunomodulatory effects of acidic exopolysaccharide produced by Lactobacillus planetarium JLAU103 on RAW264.7 macrophages
【24h】

In vitro immunomodulatory effects of acidic exopolysaccharide produced by Lactobacillus planetarium JLAU103 on RAW264.7 macrophages

机译:在Raw264.7巨噬细胞上的乳杆菌天文杆菌jlau103生产的酸性外糖的体外免疫调节作用

获取原文
获取原文并翻译 | 示例
           

摘要

Previous work from our research group has isolated and purified an acidic exopolysaccharide (named EPS103) from Lactobacillus plantarum JLAU103, which had strong in vitro antioxidant activity. In this study, we investigated the in vitro immunomodulatory activity of EPS103 in RAW264.7 macrophages with or without lipopolysaccharide (LPS) activation. The results showed that EPS103 enhanced the phagocytic activity of RAW264.7 macrophages and promoted the release of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and nitric oxide (NO) of RAW264.7 macrophages. Moreover, EPS103 reduced the excessive release of IL-6, TNF-alpha, prostaglandin E2 (PGE2), and NO, as well as inhibited the mRNA expression of IL-6, TNF-alpha, cydooxygenase-2 (COX-2), and inducible NO synthase (iNOS) of RAW264.7 macrophages activated by LPS. In mechanistic studies, EPS103 exerted immunomodulatory activity via the nuclear factor-kappa B (NF-kappa B) signaling pathway. These findings suggest that EPS103 possesses potent dual immunomodulatory activities and could be further developed as new products for functional foods or medicines. (C) 2019 Elsevier B.V. All rights reserved.
机译:我们研究小组的以往的工作已经分离和纯化了来自乳酸杆菌Jlau103的酸性外偶(名为EPS103),其具有强大的体外抗氧化活性。在这项研究中,我们在Raw264.7巨噬细胞中研究了EPS103的体外免疫调节活性,或没有脂多糖(LPS)活化。结果表明,EPS103增强了Raw264.7巨噬细胞的吞噬活性,并促进了Raw264.7巨噬细胞的白细胞介素-6(IL-6),肿瘤坏死因子-α(TNF-α)和一氧化氮(NO)的释放。此外,EPS103减少了IL-6,TNF-α,前列腺素E2(PGE2)的过度释放,以及抑制IL-6,TNF-α,COOOXYGANE-2(COX-2)的mRNA表达,诱导诱导的Raw264.7巨噬细胞的诱导酶(InOS)激活LPS。在机械研究中,EPS103通过核因子-Kappa B(NF-Kappa B)信号传导途径施加免疫调节活性。这些发现表明EPS103具有有效的双免疫调节活动,可以进一步开发为功能性食品或药物的新产品。 (c)2019 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号